11:21 AM EDT, 05/02/2025 (MT Newswires) -- ElectroCore ( ECOR ) said Friday it completed its merger with NeuroMetrix ( NURO ) , gaining ownership of the Quell Fibromyalgia Solution platform.

As part of the merger agreement, NeuroMetrix ( NURO ) shareholders received $4.49 in cash per share along with a contingent value right linked to future sales milestones of the Quell business and potential proceeds from the sale of NeuroMetrix's ( NURO ) DPNCheck business, the company said.

Following the merger, NeuroMetrix ( NURO ) became an indirect wholly owned subsidiary of electroCore, and its shares were delisted from Nasdaq on Friday.

Shares of electroCore were up 11% in recent trading.

Price: 8.40, Change: +0.83, Percent Change: +10.96